Sort
3,198 grants matching “mrna vaccine”
Mechanisms of Marburg virus gene expression
$529,282Rachel Fearns · Boston University Medical Campus · R01 · FY2019 · AI
EPITRANSCRIPTOMIC REGULATION OF CYTOMEGALOVIRUS INFECTION
$529,058Ian J. Mohr · New York University School Of Medicine · R01 · FY2025 · AI
Metabolic Control of Immune Suppression in Gliomas
$528,130Maciej S Lesniak · University Of Chicago · R01 · FY2015 · NS
Systemic RNA Delivery to Tumors
$526,391Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2019 · CA
New Materials to Deliver mRNA: Applications in Cancer Immunotherapy
$525,103Robert M. Waymouth · Stanford University · R01 · FY2024 · CA
Innate Immunity
$524,662Bali Pulendran · Emory University · U19 · FY2016 · AI
The Roles of Lymphoid Tissue Microenvironments in Guiding the Immune Response
$524,320Michael Gerner · University Of Washington · R01 · FY2019 · AI
New Materials to Deliver mRNA: Applications in Cancer Immunotherapy
$522,472Robert M. Waymouth · Stanford University · R01 · FY2021 · CA
Coronavirus vaccine development
$522,460Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
New methods for computational modeling of RNA structures
$520,040Shi-Jie Chen · University Of Missouri-Columbia · R35 · FY2025 · GM
Infection and Rapid Transmission of SARS-C0V-2 in Ferrets
$519,707Jae U Jung · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · AI
Human Papillomavirus Infection in Perinatally HIV-infected Adolescents in Asia
$519,152Annette H Sohn · Foundation For Aids Research · R01 · FY2016 · HD
Architecture of a divergent bipartite internal ribosome entry site from Giardiavirus
$518,400Brian T Wimberly · New York Structural Biology Center · R21 · FY2025 · AI
Structure and Function of Virulence Factors of Bacillus anthracis
$518,139Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Tick Immune-Developmental and Metabolic Pathways as Anti-Tick Vaccine Targets
$516,500Erol Fikrig · Univ Of Maryland, College Park · P01 · FY2025 · AI
BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERSTASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIA
$515,612Margie L. Clapper · Research Inst Of Fox Chase Can Ctr · N01 · FY2024 · CA
New Materials to Deliver mRNA: Applications in Cancer Immunotherapy
$514,997Robert M. Waymouth · Stanford University · R01 · FY2023 · CA
Determinants of resistance in human schistosomiasis
$514,059University Of Georgia (Uga) · R01 · FY2003 · AI
Global regulators converge to orchestrate metabolism, biofilm, and pathogenesis
$513,904Paula I Watnick · Boston Children'S Hospital · R01 · FY2015 · AI
A New Lipid Nanoparticle Technology Enabling Long-acting mRNA Therapy
$513,877Jinjun Shi · Brigham And Women'S Hospital · R33 · FY2024 · HL
Posttranscriptional control of gene expression
$513,285Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Small Circular mRNA Vaccines
$513,077Guizhi Zhu · University Of Michigan At Ann Arbor · R01 · FY2025 · AI
Systems biological assessment of innate responses to vaccination
$512,494Bali Pulendran · Stanford University · U19 · FY2023 · AI
New Materials to Deliver mRNA: Applications in Cancer Immunotherapy
$512,443Robert M. Waymouth · Stanford University · R01 · FY2022 · CA
REPEAT-CONTAINING RNA BINDING PROTEINS OF TRYPANOSOMES
$509,192Inna Afasizheva · Boston University Medical Campus · R01 · FY2020 · AI